The Cape Coast Metropolitan Assembly has carried out a major decongestion exercise across parts of Cape Coast today as part of efforts to restore order and improve movement within the metropolis. The ...
West Bengal Chief Minister Mamata Banerjee during a press conference regarding the ongoing Special Intensive Revision (SIR) of electoral rolls, in New Delhi, Tuesday, Feb. 3, 2026.(PTI) The Election ...
A study exploring the mechanisms behind why cognitive performance improves in response to exercise, has found that dopamine plays a key role. A study exploring the mechanisms behind why cognitive ...
The Municipal Chief Executive (MCE) for Keta, Wisdom Seade, has reaffirmed the Assembly’s commitment to improving environmental sanitation following a successful large-scale community clean-up ...
I exercise most days, but the number on the scale never moves. What’s even the point? Exercise is not very effective for weight loss, but it’s incredibly beneficial for your physical and mental health ...
Gilead Sciences GILD recently announced that it has exercised its combined option to exclusively license Assembly Biosciences’ ASMB herpes simplex virus (HSV) helicase-primase inhibitor programs. The ...
(RTTNews) - Gilead Sciences (GILD) and Assembly Biosciences (ASMB) announced Gilead has exercised its combined option to exclusively license Assembly Bio's herpes simplex virus helicase-primase ...
– Weekly Oral Helicase-Primase Inhibitor Programs' Early Data Potentially Supportive of First New Treatment for Recurrent Genital Herpes in 25 Years – “At Gilead, we develop novel antiviral ...
FOSTER CITY, Calif. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Assembly Biosciences, Inc. (Nasdaq: ASMB), today announced Gilead has exercised its ...
Gilead Sciences, Inc. (Nasdaq: GILD) and Assembly Biosciences, Inc. (Nasdaq: ASMB), today announced Gilead has exercised its combined option to exclusively license Assembly Bio’s herpes simplex virus ...
– Weekly Oral Helicase-Primase Inhibitor Programs' Early Data Potentially Supportive of First New Treatment for Recurrent Genital Herpes in 25 Years – Gilead Sciences, Inc. (Nasdaq: GILD) and Assembly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results